Lifeboat Foundation

🇬🇧FREE WEBINAR🇮🇹: https://draronica.com/free-webinar/

In this Ask Me Anything interview, Prof. Matt Kaeberlein discusses the evidence (and lack thereof) behind popular anti-aging supplements and interventions. Starting from his current research on rapamycin for healthy longevity in dogs (The Dog Aging Project), he describes the promises and perils of anti-aging medicine and shares with us some tips on how to become better critical thinkers and protect us from hype and snake oil.

Continue reading “Anti-aging Supplements: Science, Snake Oil, and How Do We Know?” »

Because it CAN be done does not mean it SHOULD be done.

We humans have not yet developed a strong understanding of unintended consequences.

Human neurons can survive — and even develop — after being transplanted into newborn rats. But are they still rats?

Continue reading “Researchers make human neurons grow inside living rat brains” »

It’s a morning routine familiar for many of us: Get that mouth clean immediately after breakfast by using a harsh toothpaste applied by an abrasive toothbrush, followed by a rinse with a mouthwash so strong it makes you wince. Dr. Kami Hoss winces, too, when he hears patients describe these habits.

Rational Virology Research For Human Health & Pandemic Prevention — Dr. Felicia Goodrum Sterling, Ph.D. Professor, Department of Immunobiology, The University of Arizona.

Dr. Felicia Goodrum, Ph.D. (https://profiles.arizona.edu/person/fgoodrum) is Interim Associate Department Head and Professor of Immunobiology, as well as Professor, BIO5 Institute, Cellular and Molecular Medicine, Molecular and Cellular Biology, Cancer Biology And Genetics Graduate Interdisciplinary Programs, at the University of Arizona.

Continue reading “Dr. Felicia Goodrum, Ph.D. — Rational Virology Research For Human Health And Pandemic Prevention” »

There’s an excessive amount of innovation embedded in right now’s cutting-edge pc chips, however not a lot of it’s as out-of-the-box because the considering that’s driving Australian startup Cortical Labs. The corporate, like so many startups with synthetic intelligence in thoughts, is constructing pc chips that borrow their neural community inspiration from the organic mind. The distinction? Cortical is utilizing precise organic neurons, taken from mice and people, to make their chips.

“We’re constructing the primary hybrid pc chip which entails implanting organic neurons on silicon chips,” Hon Weng Chong, CEO and co-founder of Cortical Labs, informed Digital Tendencies.

That is completed by first extracting neurons in two other ways, both from a mouse embryo or by remodeling human pores and skin cells again into stem cells and inducing these to develop into human neurons.

Low-cost robots that perfectly mimic parts of the human body foreshadow a future in which humanoid robots do all the work people don’t want.

Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD

Discount Links:
NAD+ Quantification: https://www.jinfiniti.com/intracellular-nad-test/
Use Code: ConquerAging At Checkout.

Continue reading “Exercise Timing Is Associated With All-Cause Mortality Risk” »

The stylish and stealthy microphone may be useful for monitoring patient health or as aids to its hearing impaired wearers.

Transcatheter mitral valve repair for heart failure patients with mitral regurgitation can reduce the long-term rate of hospitalizations by almost 50 percent, and death by nearly 30 percent, compared with heart failure patients who don’t undergo the minimally invasive procedure.

These are the breakthrough findings from a new study led by a researcher from the Icahn School of Medicine at Mount Sinai. This multi-center trial is the largest trial to examine the safety and effectiveness of transcatheter mitral-valve repair in a heart failure population using Abbott’s MitraClip system. It shows this treatment option significantly improves outcomes for patients with heart failure that do not respond to conventional treatments.

The five-year results from the “Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Device” study, or COAPT, were announced Sunday, March 5, in a Late Breaking Clinical Trial presentation at the American College of Cardiology Scientific Sessions Together with World Congress of Cardiology (ACC.23/WCC) in New Orleans, and published in The New England Journal of Medicine.